Home/Filings/4/0001562180-17-002919
4//SEC Filing

HOLBROOK KAREN A 4

Accession 0001562180-17-002919

CIK 0000842023other

Filed

Sep 7, 8:00 PM ET

Accepted

Sep 8, 4:44 PM ET

Size

16.3 KB

Accession

0001562180-17-002919

Insider Transaction Report

Form 4
Period: 2017-09-06
Transactions
  • Sale

    Common Stock

    2017-09-06$121.73/sh1,059$128,909914 total
Holdings
  • Stock Option (right to buy)

    Exercise: $91.78From: 2014-10-30Exp: 2024-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $87.39From: 2013-10-31Exp: 2023-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $70.35From: 2011-10-27Exp: 2021-10-26Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $63.03From: 2009-10-29Exp: 2019-10-28Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $101.19Exp: 2026-10-26Common Stock (3,985 underlying)
    3,985
  • Stock Option (right to buy)

    Exercise: $65.47From: 2008-10-23Exp: 2018-10-22Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $87.34From: 2016-10-29Exp: 2025-10-28Common Stock (4,260 underlying)
    4,260
  • Stock Option (right to buy)

    Exercise: $66.90From: 2012-10-25Exp: 2022-10-24Common Stock (5,000 underlying)
    5,000
  • Stock Option (right to buy)

    Exercise: $61.46From: 2010-10-28Exp: 2020-10-27Common Stock (5,000 underlying)
    5,000
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.72 to $121.728, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The option vests on the earlier of the one year anniversary of the grant date (10/27/17) or the date of Bio-Techne's 2017 annual meeting of shareholders.

Issuer

BIO-TECHNE Corp

CIK 0000842023

Entity typeother

Related Parties

1
  • filerCIK 0001288295

Filing Metadata

Form type
4
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 4:44 PM ET
Size
16.3 KB